Literature DB >> 20655262

Decrease in CD4+CD25+FoxP3+ Treg cells after pulmonary resection in the treatment of cavity multidrug-resistant tuberculosis.

Ying E Wu1, Wen Guang Peng, Ying Mu Cai, Gao Zhe Zheng, Geng Long Zheng, Jing Hua Lin, Su Wei Zhang, Ke Li.   

Abstract

OBJECTIVES: Immune regulatory mechanisms may limit the immunopathologic condition of infection with Mycobacterium tuberculosis and suppress cellular immune responses in the host. We investigated the CD4(+)CD25(+)FoxP3(+) circulating regulatory T cells (T(reg)) in patients with cavity multidrug-resistant tuberculosis (MDR-TB) before and after surgery.
METHODS: We compared the proportion of T(reg) cells in 13 patients with cavity MDR-TB pre- and postoperatively and in 10 healthy control subjects by flow cytometry using three specific markers in peripheral blood lymphocytes: cell-surface CD4 and CD25 expression and intracellular FoxP3 expression.
RESULTS: The proportion of CD4(+)CD25(high) and CD4(+)CD25(+)FoxP3(+) T(reg) was significantly higher in patients with cavity MDR-TB and at 1-month postoperatively than in healthy controls (p<0.001). The proportion of CD4(+) and CD4(+)CD25(-) cells was significantly lower in patients with cavity MDR-TB than in controls (p<0.001). Pre- and postoperative proportions of CD4(+)CD25(high) and CD4(+)CD25(+)FoxP3(+) T(reg) cells showed a positive correlation (r=0.878, p<0.001).
CONCLUSION: Circulating T(reg) cells are increased in proportion in patients with cavity MDR-TB and decreased after surgery. Infection with M. tuberculosis may induce T(reg) cell-surface molecular changes with increased numbers of cells.
Copyright © 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655262     DOI: 10.1016/j.ijid.2010.04.005

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  9 in total

1.  A case of IgG4-related tubulointerstitial nephritis with left hydronephrosis after a remission of urinary tract tuberculosis.

Authors:  Toshimi Imai; Wako Yumura; Fumi Takemoto; Atsushi Kotoda; Reika Imai; Makoto Inoue; Mitsugu Hironaka; Shigeaki Muto; Eiji Kusano
Journal:  Rheumatol Int       Date:  2012-01-05       Impact factor: 2.631

Review 2.  T regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection?

Authors:  Om Parkash; Sonali Agrawal; M Madhan Kumar
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

Review 3.  Systemic inflammatory changes and their clinical implications following thoracic cancer surgery.

Authors:  Massimiliano Fornasiero; Georgios Geropoulos; Dimitrios Giannis; Joshua Enson; Julian Aquilina; Niraj Kumar; Kunal Bhakhri; Nikolaos Panagiotopoulos
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-03-23

4.  The role of T regulatory cell-associated markers in monitoring tuberculosis treatment completion and failure.

Authors:  Sonali Agrawal; Om Parkash; Alangudi Natarajan Palaniappan; Ashok K Bhatia; Santosh Kumar; Devendra S Chauhan; M Madhan Kumar
Journal:  Immunol Res       Date:  2018-10       Impact factor: 2.829

Review 5.  The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?

Authors:  Anastasia Koch; Valerie Mizrahi; Digby F Warner
Journal:  Emerg Microbes Infect       Date:  2014-03-12       Impact factor: 7.163

6.  Clinical and Immunological Effects of rhIL-2 Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis.

Authors:  Qi Tan; Rui Min; Guan-Qun Dai; Yan-Li Wang; Li Nan; Zhen Yang; Jun Xia; Shi-Yang Pan; Huang Mao; Wei-Ping Xie; Hong Wang
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

7.  Frequency of Circulating CD4+Ki67+HLA-DR- T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture Conversion.

Authors:  Selena Ferrian; Melinda Ross; Francesca Conradie; Shaheed Vally Omar; Nazir Ismail; Francesca Little; Gilla Kaplan; Dorothy Fallows; Clive M Gray
Journal:  Front Immunol       Date:  2018-10-25       Impact factor: 7.561

8.  Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time.

Authors:  Norma A Téllez-Navarrete; Lucero A Ramon-Luing; Marcela Muñoz-Torrico; Mario Preciado-García; Karen Medina-Quero; Rogelio Hernandez-Pando; Leslie Chavez-Galan
Journal:  Mol Med       Date:  2021-07-14       Impact factor: 6.354

9.  Altered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome.

Authors:  Keira H Skolimowska; Molebogeng X Rangaka; Graeme Meintjes; Dominique J Pepper; Ronnett Seldon; Kerryn Matthews; Robert J Wilkinson; Katalin A Wilkinson
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.